Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
acetylsalicylic acid (aspirin) (1 trial)
cabozantinib (cometriq) (1 trial)
cisplatin (platinol) (1 trial)
doxycycline (vibramycin) (1 trial)
durvalumab (imfinzi) (1 trial)
Filgrastim (neupogen) (1 trial)
gemcitabine (gemzar) (1 trial)
glucarpidase (voraxaze) (1 trial)
methotrexate (1 trial)
niraparib (zejula) (1 trial)
paclitaxel (taxol) (1 trial)
ponatinib (iclusig) (1 trial)
tremelimumab (Imjudo) (1 trial)
vinblastine (velban) (1 trial)
fulvestrant (faslodex) (1 trial)
palbociclib (ibrance) (1 trial)
rogaratinib (1 trial)
Breast Neoplasms (Phase 1)
Colorectal Neoplasms (Phase 2)
Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 2)
Leukemia, Myeloid (Phase 2)
Neoplasms (Phase 1)
Urinary Bladder Neoplasms (Phase 2)
Trials (6 total)
Trial APIs (17 total)